129 related articles for article (PubMed ID: 10896030)
1. Receptor selectivity of Met-enkephalin-Arg6-Phe7, an endogenous opioid peptide, in cerebral cortex of human and rat.
Kim KW; Woo RS; Kim CJ; Cheong YP; Kim JK; Kwun J; Cho KP
Life Sci; 2000 May; 67(1):61-71. PubMed ID: 10896030
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological effects of naltriben as a ligand for opioid mu and kappa receptors in rat cerebral cortex.
Kim KW; Son Y; Shin BS; Cho KP
Life Sci; 2001 Feb; 68(11):1305-15. PubMed ID: 11233997
[TBL] [Abstract][Full Text] [Related]
3. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
Schoffelmeer AN; Hogenboom F; Mulder AH
Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
[TBL] [Abstract][Full Text] [Related]
4. Receptor binding and G-protein activation by new Met5-enkephalin-Arg6-Phe7 derived peptides.
Bozó B; Farkas J; Tóth G; Wollemann M; Szucs M; Benyhe S
Life Sci; 2000 Feb; 66(13):1241-51. PubMed ID: 10737419
[TBL] [Abstract][Full Text] [Related]
5. Characterization of [3H]Met-enkephalin-Arg6-Phe7 binding to multiple sites in rat and guinea pig cerebellum.
Benyhe S; Farkas J; Tóth G; Wollemann M
Life Sci; 1999; 64(14):1189-96. PubMed ID: 10210261
[TBL] [Abstract][Full Text] [Related]
6. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
Liu-Chen LY; Yang HH; Li S; Adams JU
J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
[TBL] [Abstract][Full Text] [Related]
7. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
[TBL] [Abstract][Full Text] [Related]
8. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
9. The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons.
Chieng B; Connor M; Christie MJ
Mol Pharmacol; 1996 Sep; 50(3):650-5. PubMed ID: 8794906
[TBL] [Abstract][Full Text] [Related]
10. Opioid peptide receptor studies. 10. Nor-BNI differentially inhibits kappa receptor agonist-induced G-protein activation in the guinea pig caudate: further evidence of kappa receptor heterogeneity.
Heyliger SO; Jackson C; Rice KC; Rothman RB
Synapse; 1999 Dec; 34(4):256-65. PubMed ID: 10529720
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens.
Izenwasser S; Búzás B; Cox BM
J Pharmacol Exp Ther; 1993 Oct; 267(1):145-52. PubMed ID: 7901389
[TBL] [Abstract][Full Text] [Related]
12. Ligand binding profiles of U-69, 593-sensitive and-insensitive sites in human cerebral cortex membranes: evidence of kappa opioid receptors heterogeneity.
Kim KW; Eun YA; Soh SM; Eun JS; Cho KP
Life Sci; 1996; 58(19):1671-9. PubMed ID: 8632704
[TBL] [Abstract][Full Text] [Related]
13. Opioid receptor regulation of the release of norepinephrine in brain.
Werling LL; Brown SR; Cox BM
Neuropharmacology; 1987 Jul; 26(7B):987-96. PubMed ID: 2821438
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of norepinephrine release from rat cortex slices by opioids: differences among agonists in sensitivities to antagonists suggest receptor heterogeneity.
Kim KW; Cox BM
J Pharmacol Exp Ther; 1993 Dec; 267(3):1153-60. PubMed ID: 8263776
[TBL] [Abstract][Full Text] [Related]
15. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex.
Heijna MH; Padt M; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
Eur J Pharmacol; 1990 Jun; 181(3):267-78. PubMed ID: 2166675
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain.
Mulder AH; Burger DM; Wardeh G; Hogenboom F; Frankhuyzen AL
Br J Pharmacol; 1991 Feb; 102(2):518-22. PubMed ID: 1673074
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the endogenous heptapeptide Met-enkephalin-Arg6-Phe7 binding in amphibian and mammalian brain.
Wollemann M; Farkas J; Tóth G; Benyhe S
Acta Biol Hung; 1999; 50(1-3):297-307. PubMed ID: 10574449
[TBL] [Abstract][Full Text] [Related]
18. Met5-enkephalin-Arg6-Phe7, an endogenous neuropeptide, binds to multiple opioid and nonopioid sites in rat brain.
Benyhe S; Farkas J; Tóth G; Wollemann M
J Neurosci Res; 1997 May; 48(3):249-58. PubMed ID: 9160247
[TBL] [Abstract][Full Text] [Related]
19. Presynaptic actions of opioid receptor agonists in ventromedial hypothalamic neurons in estrogen- and oil-treated female mice.
Devidze N; Zhang Q; Zhou J; Lee AW; Pataky S; Kow LM; Pfaff DW
Neuroscience; 2008 Apr; 152(4):942-9. PubMed ID: 18343595
[TBL] [Abstract][Full Text] [Related]
20. Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs.
Werling LL; Frattali A; Portoghese PS; Takemori AE; Cox BM
J Pharmacol Exp Ther; 1988 Jul; 246(1):282-6. PubMed ID: 2839666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]